It’s been explained on here numerous times. It is up to you to decide whether or not it is an accurate reflection of the value of the company’s assets.
Glenfidrich- you misinterpret what I said. It was a response to an earlier post that referred to SAR needing a smiling face. I have faith in the science and Tim and John.
Ripley and Num4 - my sentiments exactly. Very good scientists and people you can trust is my opinion as a long term holder. As we all know, there are many a chancer and nerdowells hidden behind a friendly face.
Mornington - Sareum has been told By the awarding body to expect the result of its grant application by the end of October. The actual date is clearly in the hands of the awarding body and out of the control of Sareum. So please don’ t say RNS in next 7 working days as you end up shooting yourself in the foot if it does not happen. We will get a result when the awarding body signs off the approval and the date is in their hands.
Markets.businessinsider.com at close on Friday 16 Oct show First Pacific Advisers as holding 62.5 Million shares - being 1.92 Percent of the Company shares?
Aber- given the emerging Scientific consensus that Immunotherapy combos are the future for Cancer treatment is it likely that Sierra will get fast track approval for patients who currently have unmet clinical needs? C
Zylo - yes very good news and the reason behind the huge Director buys and why the Sierra share price is consolidating. I have got no problem with Sierra taking it forward as they cannot be criticised for the way they conducted Phase 1/2. Bring on Phase 3 and also Orphan approval for patients with unmet needs. This is big news four us in my opinion
You never know, Sierra may drop an RNS later - share price been showing good consolidation lately coupled with som big buys. That we provide added interest to the presentation! Pure speculation.